FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Sebelius Imposes Her Plan B Science on FDAs

[ Price : $8.95]

HHS secretary Kathleen Sebelius orders FDA to reverse its internal decision and deny a Teva sNDA to allow Plan B One-Step to be ma...

FDA Program Begins Testing Compounds for Toxicity

[ Price : $8.95]

A high speed robotic screening system named Tox21, a collaboration of FDA, NIH, and EPA, today begins testing a library of 10,000 ...

FDA Extends Taliglucerase Alfa Review

[ Price : $8.95]

FDA extends the PDUFA review date for Protalaix taliglucerase alfa NDA to 5/1/12.

FDA Not Reading Kesslers Yasmin Comments

[ Price : $8.95]

FDA says a report by former FDA commissioner David Kessler cant be used at a 12/8 hearing on Yasmin contraceptive safety because i...

Guidance on Premarket Submissions for Artificial Pancreas Devices

[ Price : $8.95]

Federal Register Notice: FDA releases a draft guidance on developing premarket submissions for artificial pancreas device systems.

FDA Bars Wolfe From Yasmin Safety Hearing Panel

[ Price : $8.95]

FDA says Public Citizens Sidney Wolfe has an intellectual conflict of interest that bars him from participating on the panel of an...

FDA Eases REMS for Nplate and Promacta

[ Price : $8.95]

FDA says it is easing REMS restrictions for Nplate and Promacta by removing program registration requirements.

Advisors Asked to Comment on Yasmin Studies, Labeling

[ Price : $8.95]

FDA asks members of two advisory committees to consider the risk-benefit profile and labeling for Bayer combination oral contracep...

FDA Accepts Cell Therapeutics Lymphoma NDA

[ Price : $8.95]

FDA notifies Cell Therapeutics that a resubmitted NDA for pixantrone to treat non-Hodgkins lymphoma is considered a complete.

CGMP Problems Found at 3 Sandoz Facilities

[ Price : $8.95]

FDA warns Novartis of CGMP violations at three of its Sandoz drug manufacturing facilities.